We break down five of the week's most important news stories.
For further analysis, listen to the latest episode of The FirstTake podcast here.
NGM goes out in a whimper in NASH
Replicating Cabometyx’s success in prostate cancer may prove challenging
Tirzepatide clears final pre-regulatory hurdle
More momentum for AbbVie’s ADC aspirations in RA
To read more Friday Five articles, click here.